In this well-characterized multicenter cohort of hospitalized patients with COVID-19 from a prospective, randomized, double-blind trial, high baseline plasma sRAGE was associated with baseline severity of illness by both clinical (baseline oxygen requirement) and biologic criteria (viral antigen level and, to a lesser degree, markers of inflammation, especially IL-6). Here, IL6 is linked to COVID-19.